Viral Contamination of Biologics Manufacture—Occurrence and Mitigation
- Type: Archived Webinar
Viral contamination events are a rare occurrence in the biopharmaceutical industry. In the past, most of the reported viral contamination events have involved hamster cell production substrates. It has only been recently that we have learned about viral contaminations involving human and monkey cell production substrates. Manufacturing processes involving bacterial fermentation also are at risk of viral contamination. The viruses in this case are referred to as bacteriophage, and while these agents are not believed to represent a patient safety risk, they can wreak havoc with manufacturing processes.
Sources of viral contamination include raw materials, open vessel operations, and other less obvious sources. Small, non-enveloped viruses are the most worrisome of the viral contaminants. These may be difficult to detect, and hard to eradicate from a contaminated facility. However, risk mitigation strategies may be used to reduce the potential for contamination with these and other viruses. It is the responsibility of manufacturers to assure safety from viral contamination through raw materials (including cell banks) treatment and/or testing, process engineering, in process testing, lot release testing, and purification process validation.
This Webinar is FREE to members of SBE. Simply click 'Attend this Webinar' below and our system will recognize your log in and charge you $0.
AIChE members may join SBE for only $15. Others pay just $75. Join SBE now (processing takes about 24 hours) and return to this page with your new log-in and you will receive this webinar for FREE.
Raymond Nims brings over 37 years of experience in the biomedical sciences. He currently provides consulting services as an employee of RMC Pharmaceutical Solutions. From 2006 to 2009, Ray served in Amgen’s corporate Quality Control group, providing subject matter expertise in viral and mycoplasma testing of raw materials and products, and serving as business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, Ray directed laboratories at BioReliance performing viral safety, endotoxin, and...
Do you already own this?
Log In for instructions on accessing this content.
|AIChE Member Credits||1|
|AIChE Undergraduate Student Members||Free|
|AIChE Graduate Student Members||Free|